Dendreon
| Use attributes for filter ! | |
| Ceo | Jim Caggiano |
|---|---|
| Headquarters | Seal Beach |
| California | |
| United States | |
| Parents | Sanpower Group |
| Nanjing | |
| Number of employees | 650 |
| Founded | 1992 |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2451761 |
About Dendreon
Dendreon is a biotechnology company. Its lead product, Provenge, is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells that have been incubated with the Dendreon PAP-GM-CSF fusion protein.
